

































































The SARS-unique domain (SUD) of SARS-CoV and
SARS-CoV-2 interacts with human Paip1 to
enhance viral RNA translation
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Albrecht von Brunn4,5,**
Abstract
The ongoing outbreak of severe acute respiratory syndrome (SARS)
coronavirus 2 (SARS-CoV-2) demonstrates the continuous threat of
emerging coronaviruses (CoVs) to public health. SARS-CoV-2 and
SARS-CoV share an otherwise non-conserved part of non-
structural protein 3 (Nsp3), therefore named as “SARS-unique
domain” (SUD). We previously found a yeast-2-hybrid screen inter-
action of the SARS-CoV SUD with human poly(A)-binding protein
(PABP)-interacting protein 1 (Paip1), a stimulator of protein trans-
lation. Here, we validate SARS-CoV SUD:Paip1 interaction by size-
exclusion chromatography, split-yellow fluorescent protein, and
co-immunoprecipitation assays, and confirm such interaction also
between the corresponding domain of SARS-CoV-2 and Paip1. The
three-dimensional structure of the N-terminal domain of SARS-
CoV SUD (“macrodomain II”, Mac2) in complex with the middle
domain of Paip1, determined by X-ray crystallography and small-
angle X-ray scattering, provides insights into the structural deter-
minants of the complex formation. In cellulo, SUD enhances
synthesis of viral but not host proteins via binding to Paip1 in
pBAC-SARS-CoV replicon-transfected cells. We propose a possible
mechanism for stimulation of viral translation by the SUD of
SARS-CoV and SARS-CoV-2.
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Introduction
Coronaviruses (CoVs) are enveloped positive-sense single-stranded
RNA (+ssRNA) viruses belonging to the subfamily Coronavirinae
within the family Coronaviridae of the order Nidovirales. They
comprise four genera: alpha-, beta-, gamma-, and delta-coronavirus
(Adams & Carstens, 2012). Severe acute respiratory syndrome coron-
avirus (SARS-CoV) and Middle-East respiratory syndrome coron-
avirus (MERS-CoV), from the genus betacoronavirus, cause severe
pneumonia in humans. Both connect with high case/fatality rates.
In December 2019, another beta-CoV (SARS-CoV-2, GenBank:
MN908947) emerged and spread globally (Wu et al, 2020). SARS-
CoV-2 leads to the disease called COVID-19. The whole-genome iden-
tity between SARS-CoV and SARS-CoV-2 is about 80% (Zhou et al,
2020). In the case of SARS-CoV, it is generally agreed that the 2003
epidemic was caused by a zoonotic transmission of a bat CoV to
humans, via an intermediate host such as the civet cat (Guan et al,
2003). In case of MERS-CoV, dromedary camels have been shown to
act as a reservoir (Reusken et al, 2013), whereas the relation to simi-
lar bat CoVs (e.g., HKU4, HKU5) remains enigmatic at this point.
However, the exact zoonotic pathway is still unclear for SARS-CoV-
2. The host range of zoonotic RNA viruses is not exclusively deter-
mined by the affinity to specific receptors on the cell surface, but also
1 Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of L€ubeck, L€ubeck, Germany
2 German Center for Infection Research (DZIF), Hamburg–L€ubeck– Borstel–Riems Site, University of L€ubeck, L€ubeck, Germany
3 State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China
4 Max-von-Pettenkofer Institute, Ludwig-Maximilians-University Munich, Munich, Germany
5 German Center for Infection Research (DZIF), Munich, Germany
6 Gene Center Munich, Department of Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany
7 Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
8 Institute of Virology and Immunology, University of Bern, Bern, Switzerland
9 Department of Biology and Center for Integrated Protein Science, Ludwig-Maximilians-University Munich, Planegg-Martinsried, Germany
10 College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China
11 Institute of Molecular Medicine, University of L€ubeck, L€ubeck, Germany
*Corresponding author. Tel: +49 451 31019058; E-mail: rolf.hilgenfeld@uni-luebeck.de
**Corresponding author. Tel: +49 89 218072839; E-mail: vonbrunn@mvp.lmu.de
†These authors contributed equally to this work
ª 2021 The Authors. Published under the terms of the CC BY 4.0 licens The EMBO Journal 40: e102277 | 2021 1 of 19
by the ability of the viruses to counteract the antiviral response
exerted by the innate immune system of the host. Hijacking essential
host-cell functions such as protein synthesis and using them for their
benefit also pose intriguing capabilities of the viruses. To assess the
zoonotic potential of animal RNA viruses, it is important to charac-
terize such virus–host interactions at molecular detail. In the current
study, we investigate the association between a portion of SARS-CoV
as well as SARS-CoV-2 non-structural protein 3 (Nsp3), i.e., the
“SARS-unique domain” (SUD), and components of the translation
initiation complex including poly(A)-binding protein (PABP)-inter-
acting protein 1 (Paip1), PABP, and ribosomes of the host cell.
The SUD was proposed to only exist in SARS-CoV when the first
SARS-CoV genome sequences were analyzed (Snijder et al, 2003). It
contains three subdomains: the N-terminal, the middle, and the C-
terminal domain, for short SUD-N, SUD-M, and SUD-C. The former
two domains each adopt a macrodomain fold, and the latter one has
a frataxin-like fold (Tan et al, 2009; Johnson et al, 2010). Regions
similar to the middle and C-terminal subdomains of SUD were found
in MERS-CoV, and the C-terminal subdomain also exists in MHV
(Chen et al, 2015; Kusov et al, 2015; Ma-Lauer et al, 2016; Lei et al,
2018). In addition, SUD-like domains occur in bat CoVs related to
SARS-CoV and SARS-CoV-2, e.g., WIV16 (Yang et al, 2016) or
As6526 (Hu et al, 2017). Therefore, this region is not entirely unique
for SARS-CoV, and SUD-N, SUD-M, and SUD-C have now been
renamed as macrodomain II (Mac2), macrodomain III (Mac3), and
domain preceding Ubl2 and PLpro (DPUP), respectively (Lei et al,
2018). All these three regions exist in SARS-CoV-2 sharing an
amino-acid sequence identity of ~ 75% with SARS-CoV SUD. Hilgen-
feld and colleagues have previously shown by reverse genetics that
deletion of Mac2 leads to a 65–70% reduction in SARS-CoV replica-
tion, whereas Mac3 is absolutely essential for the activity of the
SARS-CoV replication/transcription complex (Kusov et al, 2015).
The two-domain protein Mac2–3 interacts with oligo(G) stretches in
nucleic acids, sequences which can form G-quadruplexes (Tan et al,
2007; Tan et al, 2009). In addition, Mac3 (and Mac3–DPUP) has
been reported to bind oligo(A) (Johnson et al, 2010). Furthermore,
Mac2–3 binds to the host E3 ligase, ring-finger, and CHY zinc-finger
domain-containing 1 (RCHY1) and promotes RCHY1-mediated
degradation of the antiviral protein p53. This, in turn, leads to
increased replication of SARS-CoV (Ma-Lauer et al, 2016).
Using a high-throughput yeast-2-hybrid approach to screen the
human proteome with SUD as a bait (Pfefferle et al, 2011), we have
previously identified Paip1, a component of the host translation
machinery, as an interacting partner of SUD. Paip1 acts as a positive
translation stimulator to regulate the key translation factor PABP in
the host translation system (Derry et al, 2006). Human Paip1 has
three isoforms (Martineau et al, 2008). The N-terminal 112 residues
of isoform 1 are partly absent in isoform 2 and completely lost in
isoform 3. However, the N-terminal PAM2 motif (PABP-binding
motif 2), the middle HEAT repeat domain (Paip1M; HEAT: Hunt-
ingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A),
and yeast TOR1), and the C-terminal PAM1 motif are absolutely
conserved between these three isoforms. The PAM2 (including a
conserved region of ~ 15 amino-acid residues) and PAM1 (contain-
ing an acidic region of ~ 25 amino-acid residues) interact with the
C-terminal domain (PABC) and the N-terminal RNA-recognition
motif 1 and 2 (RRM1 and 2) of PABP, respectively (Kozlov et al,
2001; Roy et al, 2002; Derry et al, 2006). The central HEAT repeat
domain, Paip1M (219 residues), is not involved in binding to PABP;
it adopts a crescent-like shape with 10 a-helices forming five HEAT
repeats, which are interrupted by two antiparallel b-strands forming
a b-hairpin protruding from the center of the molecule (Lei et al,
2011). Furthermore, Paip1 interacts with eIF-4A (Craig et al, 1998).
The Paip1:eIF-4A interaction may ensure that only intact mRNAs
are selected as translation templates (Craig et al, 1998). Paip1 also
binds to eIF-3 and further stimulates translation (Martineau et al,
2008, 2014).
In the present study, we found that SARS-CoV SUD binds Paip1
in HEK-293 cells. This interaction also exists with SARS-CoV-2. We
report the crystal structure of Mac2 (SUD-N) in complex with
Paip1M. In addition, we show that SUD enhances viral but not host
protein synthesis via interacting with Paip1 in pBAC-SARS-CoV
replicon-transfected cells. These findings suggest that in SARS-CoV-
infected cells, the virus takes advantage of the host translation
machinery for its own benefit via the SUD:Paip1 interaction.
Results
The “SARS-unique domain” interacts with poly(A)-binding
protein-interacting protein 1 in HEK-293 cells
High-throughput yeast-2-hybrid (Y2H) screening of protein––protein
interactions between the individual SARS-CoV proteins and the
human proteome had previously been performed by von Brunn and
colleagues (von Brunn et al, 2007; Pfefferle et al, 2011), leading to
the identification of many virus––host interactions. Using SUD
(Fig 1A; amino-acid residues 389–720 of SARS-CoV Nsp3; strain:
Frankfurt; GenBank: AY291315) as a bait to screen the host
proteome, Paip1 (NCBI accession no. NP_877590.1) was identified
as a binding partner. In order to confirm this interaction, we
performed split-YFP (yellow fluorescent protein) assays (Walter
et al, 2004) in human cells (HEK-293). In this assay, bait and prey
proteins were fused to the N-terminal (YFPN) and C-terminal (YPFC)
YFP fragments (or vice versa), respectively. If bait and prey proteins
interact with each other, the YFPN and YFPC fragments will form the
complete fluorescent protein and emit a yellow fluorescence when
irradiated at 514 nm. When YFPN-Paip1 and YFPC-SUD were co-
transfected into HEK-293 cells, the YFP signal was observed indicat-
ing binding of SUD to Paip1 in the cytosol of HEK-293 cells (Fig 1B).
For negative controls, YFPN-Paip1 together with YFPC or YFPC-SUD
together with YFPN were co-transfected. In addition to split-YFP, the
SUD:Paip1 interaction was also confirmed by a fluorescence-
3-hybrid (F3H) assay (Herce et al, 2013) (Appendix Fig S1A). These
results demonstrate an interaction between SUD and Paip1 in vivo.
The N-terminal SUD subdomain (SUD-N, or Mac2) interacts with
the middle domain of Paip1 (Paip1M)
We next identified the interacting regions between Paip1 and SUD
in detail. As described in the introduction, Paip1 contains the N-
terminal PAM2, the middle domain (Paip1M), and the C-terminal
PAM1 (Fig 1C). The small PAM2 (about 15 residues) and PAM1
(about 25 residues) domains interact with the C-terminal PABC
domain of PABP and the N-terminal RRM1/2 of PABP, respectively
(Fig 1C; Roy et al, 2002; Derry et al, 2006). As PAM2 is also
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involved in binding eIF-3 (Martineau et al, 2008); it is less likely that
SUD interacts with Paip1 through these two small regions as well.
The middle domain of Paip1 (Paip1M; residues Thr78-Ser296)
contains five HEAT repeats (Lei et al, 2011). Such motifs are often
involved in protein––protein interactions (Yoshimura & Hirano,
2016). Therefore, we hypothesized that Paip1M is the most likely
binding site for SUD. The split-YFP assay confirmed this assumption
(Fig 1D). Furthermore, quantification of the split-YFP signal showed
that the intensities of the signal for Paip1:SUD and Paip1M:SUD are
almost identical (Fig 1E), suggesting that other parts of Paip1 do not
contribute to binding SUD. Moreover, an F3H assay also confirmed
that Paip1M interacts with SUD in BHK cells (Appendix Fig S1).
On the other hand, SUD comprises three subdomains (Fig 1A),
namely the N-terminal Mac2 (SUD-N; Lys389-Leu526 [Nsp3
numbering]), the middle Mac3 (SUD-M; Gly527-Ser652), and the
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review). We prepared different constructs of SUD, including Mac2,
Mac2–3, and Mac3–DPUP, to test the binding capability with
Paip1M by using the split-YFP and F3H assays. Both Mac2 and
Mac2–3 interact with Paip1M, while Mac3–DPUP does not (Fig 1F
and Appendix Fig S1B). These results demonstrate that Mac2 is
essential for binding Paip1M.
We further confirmed the interaction results by gel filtration.
Paip1M and SUD were purified separately. Subsequently, these two
proteins were mixed with a molar ratio of about 1.2:1 (overnight
incubation). The mixture was subjected to size-exclusion chro-
matography. The peak of this mixture was clearly shifted compared
to the peak position of each Paip1M or SUD (Fig 1G). Next, we
investigated the peak shift in size-exclusion chromatography when
Mac2, Mac2–3, Mac3, or Mac3–DPUP was mixed with Paip1M. The
gel filtration results showed that Mac2 and Mac2–3 but not Mac3 or
Mac3–DPUP with Paip1M displayed a peak shift when compared to
the corresponding peak of each single protein (Appendix Fig S2).
Taken together, these results indicate that only Mac2 binds Paip1M.
Crystal structure of the binary complex Mac2:Paip1M
In order to elucidate the structural basis of the SUD:Paip1M interac-
tion by X-ray crystallography, we tried to crystallize SUD:Paip1M,
Mac2–3:Paip1M, and Mac2:Paip1M. These attempts only yielded
crystals for the latter complex. However, the diffractive power of the
Mac2:Paip1M crystals was poor. After trying many optimization
methods and testing over 240 crystals at the synchrotron, we
managed to collect a 3.5-A dataset. Determination of the structure of
this complex by molecular replacement failed (search models: Mac2
[PDB entry: 2W2G, Tan et al, 2009] or Paip1M [PDB entry: 3RK6,
Lei et al, 2011]). Next, we prepared SeMet-Mac2 and grew crystals
of its complex with native Paip1M. The diffraction from these crys-
tals was even worse; after testing more than 40 crystals, 5.3-A
single-wavelength anomalous dispersion (SAD) data were collected.
However, ~ 5-A diffraction data contain, in principle, sufficient
information to determine the true structure (Schröder et al, 2010).
The structure of the Mac2:Paip1M complex was finally determined
by first using the SAD data to position Mac2 in the asymmetric unit
and then employing molecular replacement to locate Paip1M. Crys-
tallographic statistics are presented in Appendix Table S1.
The overall structure of the Mac2:Paip1M complex is displayed
in Fig 2A. One Mac2:Paip1M heterodimer exists per asymmetric
unit. Mac2 adopts the typical a/b/a macrodomain fold (Fig 2A, left
image). According to the DSSP server (Kabsch & Sander, 1983), the
order of the secondary structure elements of Mac2 is a1–b2–a2–a3–
b3–b4–g1–a4–b5–a5–b6 (g: 310 helix). A central b sheet with five
predominantly parallel b strands (b3–b4–b2–b5–b6; only b3 is
antiparallel) is flanked by a1, a2, and a3 on one side, and g1, a4,
a5 on the other side. The root-mean-square difference (RMSD)
between Mac2 in the complex and in Mac2-Mac3 (PDB entry 2W2G,
chain A; Tan et al, 2009) is 0.6 A for the corresponding Ca atoms
using the Align program (Satow et al, 1986). The main structural
difference between the two Mac2 structures is located within the N-
terminal segment Lys389–Thr408. This region includes strand b1
and helix a1 in free Mac2–3 (Tan et al, 2009). However, the b-strand
is replaced by a loop in the Mac2:Paip1M complex (Fig 2B).
Paip1M displays the expected HEAT repeat fold, with 10 helices
being the dominant secondary structure elements (Fig 2A). The
RMSD is 1.1 A between Paip1M in the complex and the free protein
(PDB entry 3RK6, chain B, Lei et al, 2011). An obvious conforma-
tional change exists in the region Ile204-Thr212. In the Mac2:
Paip1M complex, this region is a long loop (Fig 2A), while it forms
a b-hairpin in free Paip1M (Lei et al, 2011). This conformational
change does not come as a surprise, because we have noticed previ-
ously that this region is very flexible (Lei et al, 2011).
The interaction surfaces between Mac2 and Paip1M show good
complementarity (Fig 2A, right image). About 840 A2 of the surface
of Mac2 and 779 A2 of the surface of Paip1M are buried upon
complex formation, according to the PDBePISA server (complex
formation significance score: 0.86 on a scale from 0 to 1, Krissinel &
Henrick, 2007). The predominant interaction regions between Mac2
and Paip1M are confined to the N-terminal loop Ile394–Leu407 of
Mac2 and to a5 (Arg160–Arg168), the central loop (Ile204–Thr212),
and the N-terminal half of a7 (Ala214–Glu223) of Paip1M.
Solution structure of the binary complex
In order to investigate the Mac2:Paip1M complex in solution, we
performed small-angle X-ray scattering (SAXS) experiments. The
SAXS data were measured at five different protein concentrations
each of Mac2, Paip1M, and Mac2:Paip1M. These data were
subjected to Guinier analysis (Putnam, 2016). The resulting Guinier
plot was used to obtain the intensity of zero-angle scattering I0 and
the radius of gyration (Rg; estimate of the overall size of the parti-
cle). According to the I0 values of the standard BSA, and of the
samples Mac2, Paip1M, and Mac2:Paip1M, the molar masses
(MWs) of the particles in these three samples were calculated
(Appendix Table S2). The MW of the particles in each sample was
close to the theoretical value of the monomer, thus indicating a
monomeric status for each protein in solution.
◀ Figure 1. SUD interacts with Paip1.
A Genome organization of SARS-CoV and schematic illustration of Nsp3 domains. DPUP: domain preceding Ubl2; Mac: macrodomain; NAB: nucleic acid-binding domain;
PLpro: papain-like protease; Ubl1: ubiquitin-like domain 1.
B SUD binding to Paip1 in HEK-293 cells as demonstrated by the split-YFP assay.
C Schematic presentation of SUD, Paip1, and PABP. Interactions between SUD and Paip1, as well as PAPB and Paip1 are indicated by red and black lines, respectively.
PAM: PABP-binding motif; Paip1M: the middle domain of Paip1; RRM: RNA-recognition motif; PABC: the C-terminal domain of PABP.
D Paip1M alone does interact with SUD.
E SUD binds to Paip1 and Paip1M with the same binding intensity. n. s.: not significant.
F The Mac2 subdomain is crucial for interacting with Paip1M.
G Paip1M and SUD interaction was confirmed in vitro by a gel filtration assay.
Data information: Scale bars represent 50 µm.
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Subsequently, ab-initio shape determination of each sample was
performed according to the SAXS curves (program DAMMIF, Franke
& Svergun, 2009). In case of Mac2, the overall shape of the SAXS-
derived model fitted well to the crystal structure of the Mac2 domain
in Mac2–3 (Tan et al, 2009; Fig 2C). However, the SAXS-derived
model exhibited an extra region when compared to the crystal struc-
tures of Paip1M and Mac2:Paip1M (Fig 2D and E). This extension
seen in the SAXS-derived model is very likely due to the 17 residues
GSHMASMTGGQQMGRGS that remained attached to the N-terminus
of Paip1M from the cloning vector pET-28a. This artificial N-terminal
extension of Paip1M had not been included in the crystallographic
model due to lack of electron density (Lei et al, 2011). The length of
the 17 additional residues was estimated by comparison to the
extended region Glu203 to Arg213 of Paip1M. In addition, the Rg
value of Paip1M is 24  1 A in solution, whereas it is 19 A when
calculated from the crystal structure (program CRYSOL; Svergun
et al, 1995) (Appendix Table S2). The 5 A difference in Rg also
indicates the larger size of Paip1M in solution compared to the crys-
tal structure. In contrast, only four artificial residues (GSHM) had
been added by the cloning procedure to the N-terminus of Mac2.
In any case, the SAXS data confirm that the Mac2:Paip1M
complex has a similar binding pattern in solution as in the crystal
structure. On the other hand, we suspected that the artificial N-
terminal 17-residue extension of Paip1M, which is quite flexible,
may be detrimental for obtaining good crystals. Therefore, a new
construct of Paip1M with only four extra residues (GSHM) was
prepared. However, the diffraction from the crystals formed by
Paip1M thus modified in complex with Mac2 was not improved.
The N-terminal region Lys389–Thr404 of Mac2 is necessary for
binding Paip1M
Due to the low resolution of the Mac2:Paip1M crystal structure, it is




Figure 2. The overall structure of Mac2 in complex with Paip1M.
A Left image: crystal structure of the complex between Mac2 (orange) and Paip1M (light blue). Mac2 possesses a three-layer a/b/a fold. a1, 2, and 3, as well as g1
and a4, 5 form the two outside layers, whereas the b sheet (b3–b4-b2–b5–b6) forms the central layer. The first 16 residues of Mac2 are shown in green. Paip1M
comprises 10 helices within two layers. a1, 3, 5, 7, and 9 form one layer while a2, 4, 6, 8, and 10 form the other. The long loop region (Ile204–Thr212) is displayed in
purple. The N and C termini of Mac2 and Paip1M (in italics) are marked. Right image: space-filling representation showing the tight interaction between Mac2 and
Paip1M.
B Left image: Fo–Fc difference density omit map (2.5r; blue) for the region Lys389–Thr408 of Mac2 (orange) in this complex. Right image: conformational change of
this region between free Mac2 (blue; PDB entry: 2W2G, Tan et al, 2009) and Mac2 in this complex.
C–E The crystal structures of Mac2 (C; blue), Paip1M (D; red; PDB entry: 3RK6, Lei et al, 2011), and Mac2:Paip1M (E) fit the shape of envelopes derived from the small-
angle X-ray scattering (SAXS) data. The blue and red dashed lines indicate the four (GSHM) and seventeen (GSHMASMTGGQQMGRGS) artificial residues remaining
from the expression vectors in Mac2 and Paip1M, resp.
Data information: Images A and C–E were prepared by using Chimera (Pettersen et al, 2004). Image B was prepared with PyMOL (Schrödinger; http://www.pymol.org).
ª 2021 The Authors The EMBO Journal 40: e102277 | 2021 5 of 19
Jian Lei et al The EMBO Journal
Paip1M; however, we observed that mainly the N-terminal region of
Mac2 is in contact with Paip1M. In order to further confirm whether
this region is essential for the interaction between the two proteins,
we deleted the N-terminal 16 amino-acid residues of Mac2 (Lys389–
Thr404; this region is shown in green in Fig 2A and contains the
segment from the N-terminus to the end of the first a-helix). Named
D16-Mac2, this protein failed to form a complex with Paip1M
according to the gel filtration assay (Fig 3A). Furthermore, we deter-
mined the binding affinity and stoichiometry between Paip1M and
Mac2 or D16-Mac2 by isothermal titration calorimetry (ITC) experi-
ments (Fig 3B and C). The dissociation constant (Kd) between Mac2
and Paip1M was determined as 15.5  1.5 lM, and the binding
stoichiometry was 0.94  0.01 with a single-site interaction
between the two proteins. A similar range of Kd values between
other host and coronavirus proteins (such as human ISG15 and
papain-like protease, Kd is about 8.6 lM) was reported before (Shin
et al, 2020). On the other hand, D16-Mac2 showed no interaction
with Paip1M (Fig 3C). The split-YFP and F3H assays confirmed that
neither D16-SUD nor D16-Mac2 bind Paip1M in HEK-293 and BHK
cells, respectively (Fig 3E and Appendix Fig S3A). Taken together,
the N-terminal Lys389–Thr404 region of Mac2 is indispensable for
the interaction with Paip1M.
Mac1, the domain preceding Mac2, does not affect the
interaction between Mac2 and Paip1M
Mac2 is located between the X domain (also called macrodomain I,
Mac1) and Mac3 (SUD-M) of Nsp3 (Fig 1A, Lei et al, 2018). Consid-
ering the important role of the N-terminal region of Mac2 in binding





Figure 3. The N-terminal 16 residues of Mac2 are important for Paip1M binding and Mac1 does not affect Mac2:Paip1 interaction.
A The Mac2 and Paip1M interaction was impaired by removing the N-terminal 16 residues as revealed by the gel filtration assay.
B Isothermal titration calorimetry (ITC) assay of Mac2 binding Paip1M. The raw calorimetric curve is displayed on top while the fitted binding isotherm curve is at the
bottom. The measured values are as follows: N = 0.94  0.01 (binding stoichiometry); Kd = 15.5  1.5 lM (dissociation constant); DH = 6,778  149 cal/mol
(standard molar enthalpy change for binding); DS = 0.716 cal/mol/K (standard molar entropy change).
C D16-Mac2 lost all binding affinity to Paip1M in the ITC experiment.
D ITC result of Mac1–2 interacting with Paip1M. The experimental results are as follows: N = 1.14  0.02; Kd = 18.6  2.5 lM; DH = 3,730  100 cal/mol;
DS = 9.14 cal/mol/K.
E, F D16-Mac2 cannot bind Paip1M, Mac1–2 binds to Paip1M in the split-YFP assay. Scale bars represent 50 µm.
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affects the Mac2 interaction with Paip1M. We prepared the Mac1–2
construct and performed the ITC assay with Mac1–2 and Paip1M
(Fig 3D). The Kd value was found to be about 18.6  2.5 lM, with
a single binding site between Mac1–2 and Paip1M. This value very
closely resembles that of the isolated Mac2 binding Paip1M (see
above). The Mac1–2:Paip1M complex was subjected to the gel filtra-
tion (S200 column) assay, and a peak shift relative to Mac1-Mac2
and Paip1M alone was observed (Appendix Fig S3B). The split-YFP
and F3H assays also confirmed the interaction between Mac1–2 and
Paip1 in vivo (Fig 3F and Appendix Fig S3C). Taken together, the
domain preceding Mac2 does not interrupt Mac2 binding to Paip1M.
SUD and PABP do not compete with each other for interaction
with Paip1
As Paip1 interacts with both SUD (Fig 1B) and PABP (Fig 1C, Craig
et al, 1998), it is necessary to investigate whether SUD competes
with PABP for interaction with Paip1. For this purpose, excess
SUD-RFP (red fluorescence protein) expressing plasmid, which
corresponds to two-fold the amount of DNA of YFPN-PABP and
YFPC-Paip1 plasmids, were co-transfected into HEK293 cells, and
interaction of respective proteins was analyzed by split-YFP assay. If
SUD competes with PABP for interaction with Paip1, the interaction
between PABP and Paip1 should be impaired in the presence of
excess SUD. However, as shown in Fig 4A, co-expression of excess
SUD-RFP does not interfere with the binding between PABP and
Paip1 (lower images in Fig 4A), when compared with the control
(upper images in Fig 4A). In addition, co-expression of excess
RFP-PABP does not result in an impaired interaction between Paip1
and SUD either (Fig 4B). Therefore, we hypothesized that PABP,
Paip1, and SUD might form a ternary complex.
SUD, Paip1, and PABP form a ternary complex
To test this hypothesis, a GFP (green fluorescence protein)-
trap-based co-immunoprecipitation (CoIP) assay was carried out.
Myc-SUD together with Paip1-HA (hemagglutinin-derived tag) or
Paip1M-HAwas co-expressed with GFP-PABP or GFP in HEK-293 cells.
Forty-eight hours post-transfection, cells were harvested for the GFP-
trap-based CoIP. As shown in Fig 4C, Paip1-HA and myc-SUD were
co-immunoprecipitated with GFP-PABP (Lane 1) but not with GFP
alone (Lane 2), suggesting that Paip1 and SUD were co-precipitated
with GFP-PABP due to PABP, not GFP. In addition, when Paip1M
instead of full-length Paip1 was co-expressed, neither Paip1M nor SUD
were co-immunoprecipitated with GFP-PABP (Lane 3). This demon-
strated that there is no physical interaction between PABP and Paip1M
or SUD. SUD could be pulled down by PABP only when full-length
Paip1 was simultaneously present (Lane 3 compared to Lane 1),
suggesting that SUD forms a complex with PABP through Paip1.
SUD enhances the binding affinity between Paip1 and PAPB
In order to test whether SUD increases or decreases the binding
affinity between Paip1 and PABP, we performed a micro-scale
A C
B
Figure 4. SUD, Paip1, and PABP form a ternary complex.
A, B SUD and PABP do not compete with each other for interacting with Paip1. (A) Excess expression of SUD-RFP does not impair the split-YFP signal between PABP and
Paip1 (lower images), compared to the control (upper images). (B) Co-expression of excess RFP-PABP does not result in an impaired interaction between Paip1 and
SUD either. RFP: red fluorescent protein. Scale bars represent 50 µm.
C GFP-trap-based co-immunoprecipitation (CoIP) assay demonstrating a complex formed by PABP, Paip1, and SUD. GFP: green fluorescent protein.
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thermophoresis (MST) assay (Fig EV1). Fluorophore-labeled His-
PABP protein was prepared and then serially diluted. Paip1 was
mixed with labeled His-PABP. These samples were mixed thor-
oughly, and measurements were performed with a Monolith NT.115
instrument (NanoTemper Technologies). The Kd value of PABP-
Paip1 is about 8.4  1.5 lM (Fig EV1A). When a constant concen-
tration of SUD protein was added to newly prepared His-PABP:Paip1
samples, the Kd value changed to 1.9  0.6 lM (Fig EV1B). As a
control, the respective constant concentration of SUD protein was
added to His-PABP alone. No binding affinity was detected
between these proteins (Fig EV1C). Therefore, SUD increases the
binding affinity between PABP and Paip1 by about 4.4-fold under
this condition.
SUD interacts with 40S and 80S ribosomes
Both PABP and Paip1 are components of the host translation initia-
tion complex. As the proteins form a ternary complex with SUD and
SUD enhances the binding affinity between Paip1 and PAPB, we
reasoned that SUD should be found in ribosomes of the host transla-
tion machinery. We carried out polyribosome assays by transfecting
HEK293T cells with plasmid constructs expressing either RFP-SUD/
c-myc-YFPN-Paip1/HA-YFPC-PABP or RFP/c-myc-YFPN-Paip1/HA-
YFPC-PABP. Cell extracts were loaded onto linear 10–50% sucrose
gradients; proteins of individual fractions were submitted to SDS–
PAGE/Western blotting and probed with antibodies directed against
RFP (RFP and RFP-SUD), c-myc (-Paip1), PABP, and 40S ribosomal
protein S6. The absorption at 260 nm (A260) of the collected frac-
tions shows weak 40S and 60S and a strong 80S peak. SUD co-elutes
with 40S ribosomal protein S6 at 40S/80S ribosomes indicating the
association with these ribosomal subunits (Fig. EV2). The eukary-
otic small ribosomal subunit (40S) plays a central role in the initia-
tion of translation.
SUD stimulates viral but not host protein synthesis in pBAC-REP-
Rluc replicon-transfected cells
Paip1 plays an important role in regulating protein synthesis (Craig
et al, 1998; Derry et al, 2006). Therefore, we tested whether SUD
influences host and viral translation due to the SUD:Paip1 interaction.
We first examined whether SUD generally stimulates translation.
To achieve this goal, a luciferase-pcDNA3 reporter plasmid carrying
Renilla luciferase under the control of the CMV (cytomegalovirus)
promoter was co-transfected with either the HA control or the SUD-
HA (C-terminal HA) fusion plasmid to HEK-293 cells. As a result,
expression of SUD leads to induction of luciferase activity by about
2.5-fold over the control (Fig 5A, left image) without mRNA level
increase (Appendix Fig S4A). This implies that SUD generally stimu-
lates protein synthesis.
Our next goal was to investigate whether SUD stimulates viral
and/or host translation in a SARS-CoV infection situation. To mimic
normal SARS-CoV infection, a SARS-CoV replicon was co-trans-
fected with either control or SUD plasmid for examination of host
and viral translation, respectively. This replicon (named pBAC-REP-
Rluc; REP: replicon; Rluc: Renilla Luciferase) with a luciferase
reporter has been constructed to mimic viral genome replication
and expression (Kusov et al, 2015). Viral plus host protein synthesis
was then tested in a ribopuromycylation assay (Schmidt et al, 2009;
Fig 5A, middle), and viral translation alone was examined in a luci-
ferase activity assay (Fig 5A, right) in parallel. In both assays, the
pBAC-REP-Rluc replicon was co-transfected with RFP control or
SUD-RFP. Interestingly, although SUD generally stimulates transla-
tion, it obviously does not enhance total protein (viral plus host
protein) translation (Fig 5A, middle). However, in the presence of
the SARS-CoV replicon, the presence of SUD leads to a strong
increase of the viral protein level (~ 9-fold, Fig 5A, right), but it
does not enhance host protein levels.
Subsequently, it is necessary to check whether the SUD:Paip1
interaction is the main reason for viral translation stimulation by
SUD. Therefore, SUD and D16-SUD were planned to be examined
for their ability to rescue pBAC-DSUD-REP-Rluc replicon expression.
However, for an unknown reason, all of our different D16-SUD
constructs (here we only show D16-SUD-RFP and YFPc-D16-SUD as
examples) exhibit very little expression (Fig 5B, left image and S4B,
middle image) although the mRNA level is normal (Fig 5B, right
image). It could be speculated that the SUD:Paip1 interaction some-
how stabilizes the SUD protein. Alternatively, a rescue assay using
the pBAC-DMac2-REP-Rluc replicon together with the Mac2 or D16-
Mac2 constructs was carried out in order to find out the function of
the SUD:Paip1 interaction for viral expression (Fig 5C), as Mac2 and
D16-Mac2 always have reasonable and comparable expression
levels (e.g., Appendix Fig S4B middle image). The results showed
that loss of Mac2, which interrupts the SUD:Paip1 interaction, leads
to a ~ 10-fold reduction of SARS replicon expression (Fig 5C, left,
lane I vs II). Co-transfection of Mac2 results in about one-third
recovery of replicon expression (Lane III vs I), while co-expression
of D16-Mac2 cannot rescue the replicon expression at all (Lane IV).
In this rescue assay, the RNA levels of the replicons were obviously
not regulated (Fig 5C, right), suggesting that translation instead of
transcription caused the difference of luciferase activity in Fig 5C
◀ Figure 5. SUD generally stimulates translation but only enhances viral protein synthesis in the replicon-transfected cells.
A Left image: SUD generally stimulates protein translation level detected by the luciferase-pcDNA3 reporter (n = 6). Middle image: SUD does not increase the amounts
of total protein synthesis (host and viral proteins) in the replicon-transfected cells. Right image: SUD augments viral protein synthesis (n = 8). HEK-293 cells growing
in 12-well plates were transfected with the indicated plasmids and replicon DNA. Twenty-four hours post-transfection, cells were harvested for Renilla luciferase
activity measurement (left and right image). For the ribopuromycylation assay, 24 h post-transfection cells were pulsed with 3 µM puromycin for 1 h at 37°C before
harvesting for Western blot analysis (middle image).
B D16-SUD protein is not detectable but the mRNA level is normal. HEK-293 cells were transfected with the indicated plasmids. Twenty-four hours post-transfection,
cells were fixed for DAPI staining (left image) or lysed for a SYBR Green qPCR assay (right image, n = 6). Scale bars represent 100 µm.
C Left image: Mac2 stimulates replication of pBAC-DMac2-REP-Rluc replicon, but D16-Mac2 does not (n = 6). Right image: Cellular RNA was isolated for qPCR assay
using primers and probes specifically recognizing SARS Nsp14 and b-actin. The relative pBAC-REP-Rluc-related replicons RNA level was calculated as the ratio of
Nsp14 RNA to b-actin RNA. n = 5.
Data information: ***P value <0.001; **P value <0.01; n. s.: not significant. Data were analyzed using t-test. Error bars represent SD.
▸
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(left image). To find out whether a higher dose of Mac2 could
recover the Renilla luciferase activity from pBAC-DMac2-Rep-RLuc,
a dose-dependent rescue assay was performed. As shown in
Fig EV3, increasing doses of Mac2 led to an almost full rescue of the
luciferase activity from pBAC-DMac2-Rep-RLuc (Lane III to V
compared with Lane I). Taken together, loss of the SUD:Paip1 inter-
action strongly impairs viral translation. The SUD:Paip1 interaction
plays an important role for viral but not host mRNA translation in
the pBAC-REP-Rluc-transfected cells.
SARS-CoV-2 SUD binds to Paip1
The SUD domains of SARS-CoV and SARS-CoV-2 (for short,
SARS2-SUD) display an amino-acid identity of 75% (Fig 6A)
prompting us to test whether SARS2-SUD also binds to Paip1. Not
surprisingly, SARS2-SUD and SARS2-Mac2 interact with Paip1
(Fig 6B and C). In addition, SARS2-Mac2 but not D16-SARS2-Mac2
bind to Paip1M (Fig 6C) implying similar functions during coron-
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Figure 6. The corresponding SUD:Paip1 interaction exists in SARS-CoV-2.
A Sequence alignment of SUD between SARS-CoV (GenBank: AY291315) and SARS-CoV-2 (GenBank: MN908947). Domains Mac2 (SUD-N), Mac3 (SUD-M), and DPUP
(SUD-C) range from K389 to L526, G527 to S652, and K653 to S720, respectively. The first 16 residues of Mac2 are boxed in blue. This figure was generated by using the
ESPript server (http://espript.ibcp.fr/ESPript/ESPript/).
B SARS-CoV-2 SUD (SARS2-SUD) interacts with Paip1 in HEK-293 cells as demonstrated by the split-YFP assay.
C SARS2-Mac2 binds to Paip1. SARS2-Mac2 but not D16-SARS2-Mac2 interacts with Paip1M.
D MERS-CoV SUD-MC (Mac3–DPUP) or XMC (Mac1–Mac3–DPUP) do not bind to Paip1.
Data information: Scale bars represent 50 µm.
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we further tested the binding behavior of the region corresponding
to Mac3–DPUP (MERS-MC) and Mac1–Mac3–DPUP (MERS-X–MC)
toward Paip1 (Fig 6D). We did not detect interactions of either
region with Paip1.
Discussion
So far, three emerging CoVs, SARS-CoV, MERS-CoV, and SARS-
CoV-2 cause severe pneumonia in humans. Several new SARS-like
bat CoVs have been discovered in China and Korea in the past few
years (Menachery et al, 2015; Kim et al, 2016; Yang et al, 2016; Hu
et al, 2017). These bat CoVs use the same receptor on host cells
(ACE2; angiotensin-converting enzyme II) as SARS-CoV or SARS-
CoV-2 (Ge et al, 2013; Menachery et al, 2015; Yang et al, 2016; Hu
et al, 2017). Hence, an outbreak of a SARS-like coronavirus (such
as SARS-CoV-2) can occur any time. In addition to receptor usage,
the potential of a zoonotic virus to establish itself in a new host will
depend on its ability to cope with the innate immune system of this
host and possibly with its capability to use the host’s protein
synthesis machinery for its own benefit. Our study provides new
insight on the latter aspect for SARS-CoV by demonstrating that the
SUD-N (Mac2) domain interacts with the host cell translation appa-
ratus via Paip1 and increases viral translation. This interaction may
offer a new antiviral target. Importantly, the domain corresponding
to SARS-CoV SUD exists in SARS-CoV-2 and is identical to 75% at
the amino-acid sequence level. The N-terminal 16 residues are
almost identical between these two viruses (Fig 6A). They are
required for binding to Paip1 (Fig 6C). Interestingly, the Mac2
domain is absent in MERS-CoV (Ma-Lauer et al, 2016). Only Mac1
(X domain), Mac3 (SUD-M), and DPUP (SUD-C) exist in this virus.
Neither MERS-CoV Mac3–DPUP (MERS-MC) nor Mac1–Mac3–DPUP
(MERS-X–MC) interact with Paip1 (Fig 6D); therefore, the Mac2:
Paip1 interaction is involved in the unique regulation of translation
in SARS-CoV and SARS-CoV-2 but not in MERS-CoV. Our results
help better understand the novel SARS-CoV-2 and other new SARS-
like CoVs that will possibly enter the human population through
future zoonotic events.
RNA viruses always seek to stimulate viral RNA translation but
inhibit host protein synthesis because of the limited cellular
resources as well as a means to block antiviral factor (e.g., inter-
feron) production. However, different viruses utilize distinct strate-
gies owing to the individual features of their mRNAs. For example,
rotavirus mRNA is only 50-capped but not 30-polyadenylated
(Fig 7A). Its NSP3 protein binds to the 30 end of the viral mRNA,
instead of PABP interacting with eIF-4G, to maintain the closed-loop
RNA for the initiation of viral RNA translation and to block host
mRNA circularization (Fig 7A, Piron et al, 1998). Differently, picor-
navirus RNA lacks the 50-cap but has a RNA stem-loop structure in
the 50-untranslated region (50-UTR). The initiation of viral RNA
translation is mediated in a cap-independent way by an internal ribo-




Figure 7. Different mechanisms of viruses regulating the host
translation system.
A Rotavirus RNAs have a 50 cap but not a 30 poly(A) tail. Its NSP3 protein
(instead of PABP) binds to the 30 end of the viral mRNA and interacts with
eIF-4G directly to maintain the closed-loop RNA for the initiation of viral
RNA translation and to block host mRNA circularization (Piron et al, 1998).
B Picornavirus RNA has an internal ribosome entry site (IRES) in the 50
untranslated region and a 30 poly(A) tail. Viral protease (2A or leader)
digests eIF-4G. The truncated eIF-4G shows higher efficiency in the IRES-
driven translation than the cap-dependent translation (Ohlmann et al,
1995; Ali et al, 2001).
C Coronavirus RNAs have a 50 cap and a 30 poly(A) tail. In our model, SUD
associates with the 40S/80S ribosome and enhances the PABP:Paip1
interaction to stimulate the host translation machinery. Meanwhile,
coronaviral Nsp1 specifically cleaves host mRNAs (green) but not viral RNAs
(Kamitani et al, 2006; Huang et al, 2011). Also, viral Nsp1 blocks host mRNA
binding to the 40S ribosome. As a result, SARS-CoV could increase the viral
RNA translation but inhibit host mRNA translation.
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et al, 2015). The picornavirus 2A protease (or the Leader protease)
cleaves eIF-4G (Fig 7B, Lei & Hilgenfeld, 2017), and the truncated
eIF-4G works more efficiently on the viral IRES-driven translation
than on the host cap-dependent translation (Ohlmann et al, 1995; Ali
et al, 2001), thereby supporting picornavirus protein synthesis.
However, coronavirus RNAs have both the 50-cap and the 30-poly(A)
tail (Fig 7C), and are thus similar to the host mRNAs. Coronavirus
protein synthesis involves the cap-dependent translation machinery
similar to the host (Nakagawa et al, 2016). Therefore, CoVs cannot
use strategies similar to rotavirus or picornaviruses.
In the present study, we confirmed that SARS-CoV Mac2 binds to
the host translation stimulator, Paip1 (Fig 1F, Appendix Figs S1B
and S2B). We also found that SUD (Mac2–Mac3–DPUP) regulates
the mRNA translation level (Fig 5A). Like host mRNAs, the genomic
and sub-genomic RNAs of CoVs are translated in a cap-dependent
manner with the RNA cap-to-tail “closed-loop” structure (Kahvejian
et al, 2001; Derry et al, 2006; Nakagawa et al, 2016). The formation
of this circular mRNA topology is the rate-limiting initiation step of
the host translation process (Kahvejian et al, 2001; Derry et al,
2006; Sonenberg & Hinnebusch, 2009; Jackson et al, 2010). The host
elements that are involved in the initiation step are important for
CoV replication. For example, Cencic et al (2011) reported that repli-
cation of human CoV 229E is significantly reduced by blocking the
interaction between eIF-4E and eIF-4G. Silencing the PABP gene
reduces the production of transmissible gastroenteritis CoV (TGEV)
(Galan et al, 2009). Binding of PABP to the 30 poly(A) of bovine CoV
or mouse hepatitis CoV (MHV) is required for virus replication
(Spagnolo & Hogue, 2000). PABP is a key factor by interacting with
the 30-poly(A) tail as well as eIF-4G to form “closed-loop” mRNA
(Kahvejian et al, 2001). The Paip1:PABP interaction facilitates this
process and enhances the efficiency of PABP (Craig et al, 1998;
Derry et al, 2006). As we mentioned above, SUD generally stimu-
lates the mRNA translation level in HEK-293 cells (Fig 5A, left) but
only stimulates the viral translation level in the replicon-transfected
cells (Fig 5A, right). However, three questions should still be
answered: (i) How does SUD enhance the translation? As we know,
a strengthened Paip1:PABP interaction enhances the translation effi-
ciency (Craig et al, 1998; Derry et al, 2006). We found that SUD
enhances the binding affinity of PABP to Paip1 by about 4.4-fold
(Fig EV1), which potentially stimulates the translational level. It can
be speculated that upon binding to SUD, Paip1 adopts a more favor-
able conformation when forming a complex with PABP. To answer
this, it will be interesting to investigate the structure of SUD:Paip1:
PABP in the future. (ii) Is SUD associated with the host translational
apparatus and does this interaction make SUD-N (Mac2) essential
for SARS-CoV? First, we tested the interactions between SUD and
ribosomes by a polysome gradient analysis assay (Fig EV2). We find
that SUD co-elutes with a 40S ribosomal subunit marker protein
(rps6) in 40S and 80S ribosomes. Initiation factors bind to this
complex and facilitate scanning of messenger RNAs and initiation of
protein synthesis. We hypothesize that SUD plays a major role for
expression of viral mRNAs within the ternary complex with PABP
and Paip1. Furthermore, we have previously answered this question
in the context of a SARS-CoV replicon where we showed that upon
deletion of this domain, SARS-CoV replication was reduced by 65–
70% (Kusov et al, 2015). Here, we further confirmed that loss of the
SUD:Paip1 interaction via Mac2 deletion leads to an about 10-fold
reduction of viral replicon activity (Fig 5C Lane II vs I), indicating
that the interaction of the domain with Paip1 is critical for viral
replication. (iii) The higher activity of the translation system should
also increase the production of host proteins. How does SARS-CoV
manage to avoid this situation, which would be unfavorable for
virus replication? SARS-CoV Nsp1 was reported to specifically
promote host but not viral mRNA degradation (Kamitani et al, 2006;
Huang et al, 2011). In addition, recent studies have shown that the
C-terminus of Nsp1 from SARS-CoV-2 blocks the mRNA channel of
40S ribosomes (Schubert et al, 2020; Thoms et al, 2020), therefore
blocking the translation of host mRNA. But mRNA carrying the
corresponding viral 50UTR can escape from translation suppression
caused by SARS-CoV and SARS-CoV-2 Nsp1 (Tanaka et al, 2012;
Schubert et al, 2020). Therefore, during infection, the host mRNA
gets degraded due to Nsp1 and host translation is blocked by the
binding of Nsp1 to the mRNA channel of 40S ribosomes. However,
viral RNA with viral 50-UTR can escape the suppression caused by
Nsp1. As a final result, although SUD unselectively stimulates trans-
lation, only viral but not host translation is enhanced. This also
supports our observations that SUD increases viral RNA (replicon)
translation but not host gene expression in pBAC-REP-Rluc-trans-
fected cells despite the enhanced activity of the translation machin-
ery (Fig 5A).
Based on these considerations, we propose a model to illustrate
how regulation of the host translation machinery through SUD is
beneficial for SARS-CoV (Fig 7C). SUD binds to 40S/80S ribosome
and enhances the interaction between Paip1 and PABP to stimulate
the general translation level. Then, viral protein Nps1 not only
specifically degrades the host mRNAs but also blocks host mRNA
binding to the 40S ribosome, leading to the inhibition of host protein
synthesis (Fig 7C). Considering that the host ribosomes interact
with both viral Nsp1 (Schubert et al, 2020; Thoms et al, 2020) and
SUD, it will be interesting to investigate further whether these two
proteins might regulate the activity of each other.
In the past 17 years, various proteins of SARS-CoV have been
used as targets for inhibitor design (Hilgenfeld & Peiris, 2013;
Hilgenfeld, 2014; Zumla et al, 2016), and recently, this has been
expanded to SARS-CoV-2 (Zhang et al, 2020), but only Remdesivir
has received limited approval for the treatment of COVID-19. In
view of the ongoing SARS-CoV-2 pandemic, it should be generally
acknowledged now that newly emerging CoVs constitute a great
threat to public health and novel approaches to drug discovery are
necessary. Identification of new virus–host protein complexes as
antiviral targets is a good strategy. However, we should notice that
since structures of such complexes are extremely scarce, the devel-
opment of antiviral approaches targeting such interactions is seri-
ously hampered. To our knowledge, three types of structures of
viral and host protein complexes are mainly available for SARS-CoV
or SARS-CoV-2. One of these is connected with the viral entry step:
Structures of the receptor-binding domain of the spike protein in
complex with the host receptor ACE2 have been reported (Li et al,
2005; Yuan et al, 2017; Lan et al, 2020; Shang et al, 2020; Wang
et al, 2020; Wrapp et al, 2020). The second type is the structure of
the spike protein interacting with a human antibody (Hwang et al,
2006; Prabakaran et al, 2006; Yuan et al, 2020). The last type is
related to the host-cell innate immune response regulated by ubiqui-
tin (Ub) or Ub-like proteins, such as the structures of SARS-CoV
papain-like protease interacting with Ub, di-Ub, or ISG15 (inter-
feron-stimulated gene 15; see Lei et al, 2018, for a review). Recently,
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the structure of the SARS-CoV-2 papain-like protease in complex
with murine ISG15 has been reported (Shin et al, 2020). In addi-
tion, the cryo-EM structures of SARS-CoV-2 Nsp1 with ribosomes
(40S/80S) were reported (Schubert et al, 2020; Thoms et al,
2020). Here, we present the crystal structure of the SARS-CoV
Mac2:host Paip1M complex involved in the regulation of viral
and host mRNA translation. More structural information on
virus:host protein complexes in this field is necessary to arrive at
a better understanding.
Materials and Methods
Recombinant production of Paip1M and SUD or SUD subdomains
The middle domain of human Paip1 (Paip1M; NCBI accession no.
NP_877590.1), which comprises residues Thr78-Ser296, was
expressed in Escherichia coli and purified according to Lei et al
(2011). SARS-CoV-2 sequences were obtained from Thao et al (2020).
The full-length SUD of SARS-CoV (strain: Frankfurt; GenBank:
AY291315) comprises 332 amino-acid residues, corresponding to
residues Lys389 to Ser720 of non-structural protein 3 (Nsp3; residue
numbering starts at N-terminus of Nsp3). It is divided into three
subdomains, namely Mac2 (SUD-N), Mac3 (SUD-M), and DPUP
(SUD-C) (Tan et al, 2009; see Lei et al, 2018 for the new names of
the three subdomains). SUD, Mac2, Mac2–3 (SUD-NM), Mac3, and
Mac3–DPUP (SUD-MC) constructs of SARS-CoV correspond to resi-
dues Lys389 to Ser720, Lys389 to Leu526, Lys389 to Ser652, Gly527
to Ser652, and Gly527 to Ser720 of Nsp3, respectively. Mac2 with
the N-terminal 16 residues deleted (D16-Mac2) comprises residues
Lys405 to Leu526. All the corresponding DNA constructs mentioned
above were amplified by polymerase chain reaction (PCR) using the
oligonucleotide primers specified in Appendix Table S2. The
primers for all the constructs contain NdeI and XhoI cleavage sites.
The digested SUD, Mac2–3 (SUD-NM), Mac3, and Mac3–DPUP
(SUD-MC) PCR products were ligated into pET-15b (Novagen),
respectively; Mac2 (SUD-N) and D16-Mac2 were ligated into pET-
28a (Novagen). Both vectors contain an N-terminal hexa-histidine
(His6) tag and a thrombin cleavage site; also, these two vectors give
rise to 4 extra residues (GSHM) at the N-terminus of the target
protein after using thrombin to remove the His-tag.
The X domain (also named Mac1) plus Mac2 (Mac1–2) construct
includes residues Glu182 to Leu526 of Nsp3. The two primers for this
construct contain BamHI and XhoI cleavage sites (Appendix Table S2).
The digested Mac1–2 PCR product was ligated into pET28a, which
leaves 17 extra residues (GSHMASMTGGQQMGRGS) at the N-terminus
of theMac1–2 protein.
The pET15b- and pET28a-related recombinant plasmids
mentioned above were verified by sequencing (MWG Eurofins).
Correct plasmids were transformed into E. coli strain Tuner (DE3;
Novagen). Bacteria were incubated at 37°C overnight in 50 ml LB
medium with ampicillin (50 lg/ml)/chloramphenicol (34 lg/ml)
and kanamycin (25 lg/ml)/chloramphenicol (34 lg/ml), respec-
tively. Pre-cultures were inoculated into 2 l LB medium after 12 h.
When the OD600 of the 2-l culture reached about 0.8, overexpression
of the target gene was induced for 8 h with 0.5 mM isopropyl-D-
thiogalactoside (IPTG) at 30°C. Then, cultures were centrifuged for
25 min at 7,300 g and 4°C. Subsequently, the collected cells were
resuspended in 30 ml buffer A (20 mM Tris–HCl pH 8.5, 500 mM
NaCl, and 10 mM imidazole) and lysed by sonication on ice. Lysates
were centrifuged for 1 h at 48,384 g and 4°C to remove the cell
debris. Supernatants were applied to a HisTrapTM nickel column (GE
Healthcare), and the His-tagged proteins were eluted with buffer B
(20 mM Tris–HCl pH 8.5, 500 mM NaCl, and 500 mM imidazole)
using a linear gradient. In order to remove the His-tag, thrombin
(Sigma-Aldrich) was added to the purified proteins overnight at 4°C.
The next day, target proteins were again purified by nickel column
chromatography to remove the uncleaved His-tagged protein. All
flow-through proteins (without His-tag) from the nickel column
were subsequently purified by gel filtration (HiLoadTM 16/60
Superdex 75 column, GE Healthcare) using buffer C (20 mM Tris–
HCl pH 8.5, 150 mM NaCl). The quality of target proteins was
inspected by SDS–PAGE.
Furthermore, selenomethionine (SeMet) SUD-N (Mac2) protein
was prepared. The Mac2-pET28a plasmid was transformed into
E. coli strain SoluBL21TM (Genlantis). Transformed cells were grown
in 1 l M9 medium at 37°C. When the OD600 of the 1-l culture had
reached 0.8, L-selenomethionine and six other amino acids (lysine,
threonine, phenylalanine, leucine, isoleucine, and valine) were
added to the culture. After 15 min, Mac2 gene expression was
induced for 8 h at 30°C by the addition of ITPG (final concentration
0.5 mM). The remaining steps (e.g., culture harvesting and protein
purification) were done as described above.
Complex formation and gel filtration assay
Purified Paip1M was mixed with SUD, Mac2–3, Mac2, Mac3, Mac3–
DPUP, or D16-Mac2 proteins. The molar ratio of Paip1M to SUD
was 1.2:1, while the molar ratio of Paip1M to the other constructs
(Mac2–3, Mac2, Mac3, Mac–DPUP, or D16-Mac2) was 1:1.2.
Mixtures were incubated at 4°C overnight. Subsequently, they were
purified by gel filtration (HiLoadTM 16/60 Superdex 75 column, GE
Healthcare) using buffer C. The peak position of each binary
mixture was compared to the peaks of the corresponding single
proteins to detect whether or not a complex was formed. The result
was further confirmed by SDS–PAGE. The peak position of the D16-
Mac2 and Paip1M mixture was compared to the peak of the Mac2:
Paip1M complex.
Differently, the mixture of Mac1–2 (X domain plus SUD-N) and
Paip1M (molar ratio = 1:1.2) was purified by Superdex 200 column
chromatography (GE Healthcare).
Crystallization and diffraction data collection
The purified complexes SUD:Paip1M, Mac2–3:Paip1M, and Mac2:
Paip1M were concentrated to about 10 mg/ml in buffer C. Crystal-
lization trials for each complex were performed at 289 K by employ-
ing the sitting-drop vapor-diffusion method with 0.25 µl of protein
and 0.25 µl of reservoir using a Phoenix crystallization robot (Art
Robbins). The following commercially available screens were used:
IndexTM, SaltRxTM 1 & 2, Crystal ScreenTM 1 & 2, PEG/Ion ScreenTM 1 &
2, and PEG RxTM 1 & 2 (Hampton Research), as well as Protein
Complex Suite (Qiagen), Protein Complex Kit, and Low-ionic
Strength Kit (Sigma). Crystals were only obtained for Mac2:Paip1M
under several conditions: Protein Complex Suite no. 14 (0.1 M
calcium acetate, 0.1 M sodium acetate pH 4.5, 10% PEG 4000) and
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no. 25 (0.15 M (NH4)2SO4, 0.1 M Tris pH 8.0, 15% PEG 4000),
Protein Complex Kit no. 9 (0.1 M (NH4)2SO4, 0.1 M HEPES pH 7.5,
15% PEG 3350), and low-ionic strength no. 21 (0.05 M MES-Na pH
6.0, 4% PEG 3350). After optimization of the crystallization under all
conditions listed above, the best crystals were obtained within one
day from 0.1 M (NH4)2SO4, 0.1 M HEPES pH 7.3, 18% PEG 3350,
15% glycerol. These crystals were shock-cooled in liquid nitrogen.
Diffraction of X-rays by these crystals was poor and anisotropic.
We tried many optimization methods (e.g., various crystallization
temperatures, additives, and dehydration of the crystals); different
cryo-protectants were also tested. Over 240 crystals were tested at
beamline 14.2 of the BESSY II synchrotron (Berlin, Germany) and
beamline P11 of PETRA III, DESY (Hamburg, Germany). Finally, a
native dataset to 3.5 A was collected at a wavelength of 0.9184 A at
BESSY. However, the structure determination of this complex by
molecular replacement (MR) failed despite the availability of the X-
ray structures of the isolated components, Mac2 (PDB entry: 2W2G,
Tan et al, 2009) and Paip1M (PDB entry: 3RK6, Lei et al, 2011).
Therefore, SeMet-Mac2 protein was prepared. Crystals of Paip1M:
SeMet-Mac2 were obtained under the same crystallization condi-
tions used for the native protein complex, 0.1 M (NH4)2SO4, 0.1 M
HEPES pH 7.3, 18% PEG 3350, 15% glycerol. Diffraction of X-rays
by these crystals was still poor. After testing over 40 crystals, a 5.3-
A SeMet single-wavelength anomalous dispersion (SAD) dataset
was collected at a wavelength of 0.97968 A (the absorption edge of
selenium) at beamline 14.2 of BESSY II.
All datasets were processed using the program XDS (Kabsch,
2010), and the crystals were nearly isomorphous in the native and
SAD datasets. The space group was P3121, with unit-cell parameters
a = b = 92.4 A, c = 166.6 A.
Experimental phasing and model refinement
Using the Paip1M:SeMet-Mac2 SAD data, the phases for this binary
complex were finally determined by combining the SAD and MR
methods. First, all four selenium positions of Mac2 (except that for
the selenium atom from the extra N-terminal GSHM residues remain-
ing from the cloning vector) were successfully identified using
ShelxD (Sheldrick, 2010), and the correct hand for the substructure
was determined with ShelxE (Sheldrick, 2010). Then, the atomic
coordinates of Mac2 were fixed according to the selenium positions,
and Paip1M was located with the structure of the isolated protein
(PDB entry: 3R6K, Lei et al, 2011) as search model (program
MOLREP, Vagin & Teplyakov, 2010). On the basis of the resulting
electron density map, an initial Mac2:Paip1M complex model was
built using Coot (Emsley et al, 2010). This model was refined using
BUSTER (Bricogne et al, 2017), complemented by model rebuilding
rounds using Coot. Attempts to include higher-resolution data did
not lead to improvements of the electron density maps. The final
refinement statistics are presented in Appendix Table S1.
Small-angle X-ray scattering
Small-angle X-ray scattering (SAXS) measurements for Mac2,
Paip1M, and Mac2:Paip1M were performed at the EMBL BioSAXS
beamline P12 (Blanchet et al, 2015), DESY, Hamburg, Germany. A
2D photon-counting Pilatus 2 M detector was used to record the
scattered X-rays. The sample-to-detector distance was 3.0 m. A
series of different protein concentrations for each sample was
prepared. The final concentrations of Mac2 were 5.6, 2.8, 1.3, 0.7,
and 0.3 mg/ml. The concentrations of Paip1M were 16.2, 8.1, 4.1,
2.0, and 1.0 mg/ml, while the concentrations of the binary complex
were 15.9, 7.9, 4.0, 2.0, and 1.0 mg/ml. All concentrations were
determined by a NanoDrop ND-1000 (Thermo Scientific). All
samples were in buffer C with 2 mM DTT to avoid the formation of
unspecific disulfide bonds at high protein concentrations. Then, all
samples were measured with an X-ray wavelength of 1.24 A at 20°C.
The initial data were automatically processed by using the
pipeline SASFLOW at DESY (Franke et al, 2012). The molecular
masses (MW) of all scattering samples were obtained by the
equation MW(BSA)/I0(BSA) = MW(X)/I0(X); X stands for the
target protein, I0 is the intensity of zero-angle scattering. A
Guinier plot was used to evaluate the sample distribution. All
Guinier plots were linear, indicating monodispersity of the sample
solutions at every protein concentration. Subsequently, all SAXS
measurement curves (five protein concentrations for each sample)
were merged into one average curve for each sample by using
the program PRIMUSqt (Konarev et al, 2003). The ab-initio shape
determination of each sample was carried out by using the
program DAMMIF (Franke & Svergun, 2009).
Isothermal titration calorimetry
The binding affinity between Paip1M and Mac2, D16-Mac2, or
Mac1–2 was determined at 25°C using a VP-ITC titration calorimeter
(MicroCal). The freshly purified Mac2, D16-Mac2, or Mac1–2 was
concentrated to 120 lM, and Paip1M was concentrated to 1,000 lM
in buffer C.
About 2 ml Mac2, D16-Mac2, or Mac1–2 was added into the
sample cell. About 300 µl Paip1M was placed in the injection
syringe for each ITC experiment. The dilution heat was measured
by injecting Paip1M into the buffer alone, for control. The experi-
ments were carried out by injecting Paip1M into solutions of Mac2,
D16-Mac2, or Mac1–2. The data obtained were then processed by
using the MicroCal ORIGIN software.
Micro-scale thermophoresis-binding assay
The His-PABP-pET28a plasmid was synthesized by General Biol
(China). Expression and purification of His-PABP protein and of
Paip1 and SUD proteins without His-tag was performed as described
above. For the MST assay, all proteins were dissolved in 20 mM
HEPES, 150 mM NaCl, 0.05% Tween-20, pH 8.0 (named HEPES
buffer in the following). Purified His-PABP was labeled following
the instructions of Monolith His-Tag Labeling Kit RED-tris-NTA 2nd
Generation (NanoTemper Technologies) and then diluted in HEPES
buffer at the final concentration of 50 nM. After 30 min incubation
at room temperature, fluorophore-labeled His-PABP was centrifuged
for 10 min at 4°C at 15,000 g. Paip1 was serially diluted with
HEPES buffer starting from the highest concentration of 140 lM.
Then, supernatant of fluorophore-labeled PABP was added to Paip1
serial dilutions with equal volumes. These reaction samples
were mixed completely by pipetting and loaded into standard capil-
laries for measurement at 22°C, 40% LED-power, and medium
MST-power using a Monolith NT.115 instrument (NanoTemper
Technologies). Data from two independent measurements of
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fluorescence signal corresponding to MST-On time were analyzed
using the MO. Affinity Analysis software (NanoTemper Technolo-
gies). His-PABP:Paip1 samples with SUD (at the final concentra-
tion of 19 lM/tube) were measured at the same conditions. SUD
(at the final concentration of 19 lM/tube) was added to His-PABP
as a control.
Polyribosome gradient analysis
HEK-293T cells were cultivated in Dulbecco’s modified Eagle’s
medium (DMEM, Gibco) supplemented with 10% fetal bovine
serum (FBS, Gibco), 1× penicillin/streptomycin (Gibco), and 1×
GlutaMAX (Gibco). Plasmids pDEST-c-myc-YFPN-Paip1 and pDEST-
HA-YFPC-PABP, pDEST-RFP-SUD, pDEST-RFP were transfected with
Lipofectamine 3000 (ThermoFisher) following the manufacturer’s
protocol and HEK-293T cells were grown for additional 40 h after
transfection. Before harvesting, cycloheximide (100 µg/ml) was
added to the media for 15 min at 37°C to prevent ribosome run-off.
Cells were washed with ice-cold PBS supplemented with 100 µg/ml
cycloheximide and detached from the cell culture dishes through
scraping. Cells were resuspended in lysis buffer (20 mM Hepes-KOH
[pH 7.5], 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.5% NP-40,
100 µg/ml cycloheximide, 20 U/ml RNase inhibitor, and EDTA-free
protease inhibitor) and incubated for 5 min on ice. The lysate was
passed six times through a 23-gauge needle and cleared by centrifu-
gation twice at 20,000 g for 10 min. Equivalent amounts of each
sample (according to absorption at 260 nm) were loaded on linear
10–50% sucrose gradients (20 mM Hepes-KOH [pH 7.5], 100 mM
KCl, 5 mM MgCl2, 1 mM DTT, and EDTA-free protease inhibitor),
and samples were separated at 202,048 g for 2.5 h using a SW40 Ti
rotor (Beckmann Coulter). The gradients were fractionated with a
Biocomp piston gradient fractionator, and the absorption at 260 nm
was measured with a Biocomp Triax flow cell. The fractions were
precipitated with trichloroacetic acid and used for subsequent
Western blot analysis.
Plasmid constructs for in vivo assays
The fragments c-myc-YFPN (aa 1–155) and HA-YFPC (aa 156–239)
were amplified (using the primers listed in Appendix Table S2) from
the template plasmids pSPYNE-35S and pSPYCE-35S (Walter et al,
2004), respectively. The obtained PCR fragments were subsequently
cloned into the pTREX-dest30-PrA Gateway-compatible vector
(Pfefferle et al, 2011) via AgeI and XhoI cleavage sites or into the
pTREX-dest30-PrA Gateway-compatible vector via SpeI and ApaI
sites to replace the protein A tag, yielding pDEST-c-myc-YFPN and
pDEST-HA-YFPC or pDEST-ct-c-myc-YFPN and pDEST-ct-HA-YFPC
vectors. SUD, Paip1, PABP, and the truncated sequences of SUD and
Paip1 amplified with corresponding primers (Appendix Table S2)
were first BP Gateway-cloned into the pDONR207 vector and subse-
quently LR-cloned into pDEST-c-myc-YFPN/pDEST-HA-YFPC/
pDEST-ct-c-myc-YFPN/pDEST-ct-HA-YFPC vectors, yielding constructs
for the split-YFP assays.
For the fluorescent-3-hybrid (F3H) assays, the Gateway rfB
cassette was amplified with designed primers (Appendix Table S2)
from the Gateway destination vector pTREX-dest30-PrA and then
cloned into pNLS-TagRFP and pNLS-TagGFP vectors (Dambacher
et al, 2012) via XhoI and HpaI sites, yielding pNLS-TagRFP GW and
pNLS-TagGFP GW Gateway-compatible vectors. Paip1, SUD, and
their truncated sequences were finally cloned into pNLS-TagRFP
GW and pNLS-TagGFP GW via the LR reaction.
For some of the luciferase activity assays and qPCR, SUD and
its truncated constructs were cloned into the pDEST-ct-HA vector
via the LR Gateway reaction. To examine the subcellular co-local-
ization of PABP, Paip1, and SUD, the RFP and GFP fragments
without nuclear localization signal (NLS) were amplified with
designed primers (Appendix Table S2) and subsequently cloned
into pTREX-dest30-PrA via AgeI and XhoI sites, or into pTREX-
dest30-ct-PrA via SpeI and ApaI sites, to replace the protein A
tag, yielding pDEST-RFP and pDEST-GFP or pDEST-ct-RFP and
pDEST-ct-GFP destination vectors. PABP, Paip1, and SUD were
cloned into pDEST-RFP/GFP and pDEST-ct-RFP/GFP via the LR
Gateway reaction. For the GFP-trap-based co-immunoprecipitation
assay, Paip1, Paip1M, and SUD constructs were cloned into
pDEST-ct-HA and pDEST-N-c-myc vectors via the LR Gateway
reaction, respectively.
Cells and transfection
HEK-293 cells were cultured in Dulbecco’s modified Eagle medium
(DMEM) containing 10% FBS and 1% penicillin/streptomycin. Plas-
mids were transfected into cells by using Lipofectamine 3000 (Invit-
rogen) when the cells were 70% confluent.
For the split-YFP assay, all related proteins were first checked in
the Western blot (Appendix Fig S4B); then, cells were seeded
directly on coverslips and cultured in 24-well plates. Pictures were
subsequently taken with a Leica DM4000 B fluorescence microscope
24 h after transfection.
For the Luciferase Activity Assay and qPCR, HEK-293 cells were
seeded on 96-well plates. 5 ng pRL Renilla Luciferase control
reporter together with 200 ng SUD, Mac2, or D16-Mac2 expressing
plasmid DNA was co-transfected to each well. Cells were harvested
24 h post-transfection for further measurement.
For the fluorescence-3-hybrid assay, BHK cells containing lac
operator repeats (Tsukamoto et al, 2000) were seeded on coverslips
and cultured in DMEM with 10% FCS. TagGFP- and TagRFP-fused
constructs were transfected into the cells together with the GBP-LacI
construct (Rothbauer et al, 2006) using polyethylenimine (Sigma).
About 16 h later, cells were fixed with 3.7% formaldehyde for
10 min and then washed three times with PBST (PBS with 0.02%
Tween) and stained with DAPI (200 ng/ml) to show the nucleus.
Samples were mounted in Vectashield medium (Vectors Laborato-
ries). Samples were analyzed using a laser scanning confocal micro-
scope TCS SP5 (Leica) with a 63×/1.4 NA oil immersion objective as
described (Dambacher et al, 2012). A 488-nm argon laser was used
to illuminate TagGFP. DAPI and TagRFP were excited by a 405-nm
diode laser and a 561-nm diode-pumped solid-state laser, respec-
tively. Digital images were recorded by a PMT detector with a frame
size of 512 × 512 pixels.
Luciferase activity assay
Cells were washed once with PBS and put on ice. Subsequently,
40 µl/well of Renilla Lysis Buffer (Promega) were added. After 20 min
of shaking on ice, the lysate was transferred to a 96-well white poly-
styrene microplate (Greiner Bio-One). The luciferase activity was
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measured with a FLUOstar OPTIMA-Fluorescence plate reader (BMG
Labtech). Experiments were performed in at least triplicates.
Ribopuromycylation assay
The ribopuromycylation assay was carried out as described else-
where (Schmidt et al, 2009). HEK-293 cells growing in a 12-well
plate were transfected with the indicated plasmids and replicon via
Lipofectamine 3000 (Invitrogen). Twenty-four hours post-transfec-
tion, the cells were pulsed with 3 µM puromycin for 1 h at 37°C
before harvesting for Western blot analysis.
Probe-based qPCR
RNA was extracted with the ISOLATE RNA Mini Kit (Bioline) and
quantified by real-time PCR using SensiFASTTM Probe Hi-ROX One-
Step Kit (Bioline) allowing reverse transcription and PCR amplifi-
cation in a single step. The real-time PCR was performed in a Roche
LightCycler 96. The Renilla luciferase, b-actin, and pBAC-SARS-CoV
replicon qPCR primers are listed in Appendix Table S2. Experiments
were performed in at least triplicates.
SYBR Green qPCR
RNA was extracted with the ISOLATE RNA Mini Kit (Bioline), and
1st cDNA was isolated with SuperScriptTM IV Reverse Transcriptase
Kit (Invitrogen). The SYBR green qPCR was carried out by using
AceQ qPCR SYBR Green Master Mix Kit (Vazyme Biotech) in a
Roche LightCycler 96.
Co-immunoprecipitation and Western blotting
pDEST-GFP-PABP or pDEST-GFP, pDEST-Paip1-HA or pDEST-
Paip1M-HA, and pDEST-c-myc-SUD were co-transfected into HEK-
293 cells growing in 10-cm cell culture dishes. Cells were harvested
48 h post-transfection. GFP-Trap_A beads for immunoprecipita-
tion of GFP-Fusion Proteins (ChromoTek) were used to pull down
the complex of GFP-PABP via its standard protocol under native
conditions. The eluted samples and total cell lysates were then
analyzed by Western blotting. The performed Western blotting
protocol was described elsewhere (Carbajo-Lozoya et al, 2014).
Antibodies used for Western blots
Anti-HA: Invitrogen (Cat. No. 26183, 1:10,000 dilution), anti-GFP:
Invitrogen, (Cat. No. A-6455, 1:1,000 dilution), anti-RFP: Invitrogen,
(Cat. No. MA5-15257, 1:1,000 dilution), anti-PABP: Sigma-Aldrich,
(Cat. No. P6246, 1:2,000 dilution), anti-puromycin: (Millipore, [Cat.
No. MABE341, 1:100,000 dilution], anti-vinculin: Sigma-Aldrich,
[Cat. No. V9264, 1:1,000 dilution], anti-b-actin: Santa Cruz, [Cat. No.
sc-47778, 1:500 dilution], anti-myc: Roche [9E10], 1:300 dilution).
Data availability
Atomic coordinates and structure factors for the Mac2:Paip1M
complex have been deposited in the Protein Data Bank with acces-
sion code 6YXJ (https://www.rcsb.org/structure/6YXJ).
Expanded View for this article is available online.
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